Skip to main navigation Skip to search Skip to main content

SPIR: Multivalent QS-18 protein nanoparticles for a broadly protective influenza virus vaccine

Project: Research

Project Details

StatusFinished
Effective start/end date09/30/2310/31/25

Funding

  • National Institute of Allergy & Infectious Disease: $199,292.00